{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:14:03Z","timestamp":1793726043189,"version":"4.6.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010751","name":"National Fund For Scientific Technological and Technological Innovation Development","doi-asserted-by":"publisher","award":["N084-2016"],"award-info":[{"award-number":["N084-2016"]}],"id":[{"id":"10.13039\/501100010751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006292","name":"Infectious Diseases Society of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"National Institutes of Health Fogarty International Center","doi-asserted-by":"publisher","award":["D43-TW010074"],"award-info":[{"award-number":["D43-TW010074"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-AI107028"],"award-info":[{"award-number":["R01-AI107028"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["OAC1920103"],"award-info":[{"award-number":["OAC1920103"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Humanidades, Ciencias y Tecnolog\u00edas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Americas"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.lana.2025.101090","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T14:08:04Z","timestamp":1744898884000},"page":"101090","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Immunologic changes in the peripheral blood transcriptome of individuals with early-stage chronic Chagas cardiomyopathy: a cross-sectional study"],"prefix":"10.1016","volume":"45","author":[{"given":"Carolina","family":"Duque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yagahira E.","family":"Castro-Sesquen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"DeToy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneider A.","family":"Gutierrez Guarnizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Jahanbakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Malaga Machaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4668-225X","authenticated-orcid":false,"given":"Monica","family":"Miranda-Schaeubinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira","family":"Chakravarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Adamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kawsar R.","family":"Talaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Gilman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1535-2530","authenticated-orcid":false,"given":"Monica R.","family":"Mugnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.lana.2025.101090_bib2","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.amjmed.2020.05.022","article-title":"Chagas disease: epidemiology and barriers to treatment","volume":"133","author":"Mills","year":"2020","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.lana.2025.101090_bib3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1473-3099(01)00065-2","article-title":"Clinical and epidemiological aspects of Chagas disease","volume":"1","author":"Prata","year":"2001","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.lana.2025.101090_bib4","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1161\/CIR.0000000000000599","article-title":"Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the American Heart Association","volume":"138","author":"Nunes","year":"2018","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.lana.2025.101090_bib5","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","article-title":"Randomized trial of benznidazole for chronic Chagas' cardiomyopathy","volume":"373","author":"Morillo","year":"2015","journal-title":"N Engl J Med"},{"issue":"9723","key":"10.1016\/j.lana.2025.101090_bib6","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease","volume":"375","author":"Rassi","year":"2010","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.lana.2025.101090_bib7","article-title":"Clinical and epidemiological characterization of acute Chagas disease in Casanare, Eastern Colombia, 2012-2020","volume":"8","author":"Rincon-Acevedo","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"15","key":"10.1016\/j.lana.2025.101090_bib8","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1080\/14656566.2019.1650915","article-title":"An evaluation of benznidazole as a Chagas disease therapeutic","volume":"20","author":"Caldas","year":"2019","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"10.1016\/j.lana.2025.101090_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006567","article-title":"Electrocardiographic abnormalities in Chagas disease in the general population: a systematic review and meta-analysis","volume":"12","author":"Rojas","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.lana.2025.101090_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000632","article-title":"Electrocardiographic abnormalities in elderly chagas disease patients: 10-year follow-up of the Bambui Cohort Study of Aging","volume":"3","author":"Ribeiro","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.lana.2025.101090_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.002476","article-title":"Fascicular ventricular arrhythmias: pathophysiologic mechanisms, anatomical constructs, and advances in approaches to management","volume":"10","author":"Kapa","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"20","key":"10.1016\/j.lana.2025.101090_bib12","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1161\/CIRCULATIONAHA.111.019893","article-title":"Atrial fibrillation pathophysiology: implications for management","volume":"124","author":"Iwasaki","year":"2011","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.lana.2025.101090_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009502","article-title":"DNA damage and oxidative stress in human cells infected by Trypanosoma cruzi","volume":"17","author":"Florentino","year":"2021","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.lana.2025.101090_bib14","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1086\/342510","article-title":"Trypanosoma cruzi parasitemia in chronic Chagas disease: comparison between human immunodeficiency virus (HIV)-positive and HIV-negative patients","volume":"186","author":"Sartori","year":"2002","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.lana.2025.101090_bib15","article-title":"Monitoring the parasite load in chronic Chagas disease patients: comparison between blood culture and quantitative real time PCR","volume":"13","author":"D'Avila","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lana.2025.101090_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.actatropica.2012.08.020","article-title":"Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial","volume":"125","author":"Moreira","year":"2013","journal-title":"Acta Trop"},{"issue":"2","key":"10.1016\/j.lana.2025.101090_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ajcp\/aqw098","article-title":"Pathology of chronic Chagas cardiomyopathy in the United States: a detailed review of 13 cardiectomy cases","volume":"146","author":"Kransdorf","year":"2016","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"10.1016\/j.lana.2025.101090_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens11121402","article-title":"The characterization of cardiac explants reveals unique fibrosis patterns and a predominance of CD8+ T cell subpopulations in patients with chronic Chagas cardiomyopathy","volume":"11","author":"Diaz","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.lana.2025.101090_bib19","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.3389\/fimmu.2018.01929","article-title":"The unsolved jigsaw puzzle of the immune response in chagas disease","volume":"9","author":"Acevedo","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.lana.2025.101090_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijcard.2014.10.133","article-title":"Infectious agents and inflammation in donated hearts and dilated cardiomyopathies related to cardiovascular diseases, Chagas' heart disease, primary and secondary dilated cardiomyopathies","volume":"178","author":"Mangini","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.lana.2025.101090_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2021.105079","article-title":"Detecting imperative genes and infiltrating immune cells in chronic Chagas cardiomyopathy by bioinformatics analysis","volume":"95","author":"Zhou","year":"2021","journal-title":"Infect Genet Evol"},{"issue":"2-3","key":"10.1016\/j.lana.2025.101090_bib22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-3083.2007.01987.x","article-title":"Locally produced survival cytokines IL-15 and IL-7 may be associated to the predominance of CD8+ T cells at heart lesions of human chronic Chagas disease cardiomyopathy","volume":"66","author":"Fonseca","year":"2007","journal-title":"Scand J Immunol"},{"issue":"3","key":"10.1016\/j.lana.2025.101090_bib23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-3083.2005.01668.x","article-title":"Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes","volume":"62","author":"Vitelli-Avelar","year":"2005","journal-title":"Scand J Immunol"},{"issue":"8","key":"10.1016\/j.lana.2025.101090_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001294","article-title":"Increased CD4+\/CD8+ double-positive T cells in chronic Chagasic patients","volume":"5","author":"Giraldo","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lana.2025.101090_bib25","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3389\/fimmu.2019.00800","article-title":"Evidence of different IL-1 beta activation pathways in innate immune cells from indeterminate and cardiac patients with chronic Chagas disease","volume":"10","author":"Medeiros","year":"2019","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.lana.2025.101090_bib26","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCULATIONAHA.106.624296","article-title":"Pathogenesis of chronic Chagas heart disease","volume":"115","author":"Marin-Neto","year":"2007","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.lana.2025.101090_bib27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/infdis\/jiw540","article-title":"Blood gene signatures of Chagas cardiomyopathy with or without ventricular dysfunction","volume":"215","author":"Ferreira","year":"2017","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.lana.2025.101090_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011474","article-title":"Differential expression profile of genes involved in the immune response associated to progression of chronic Chagas disease","volume":"17","author":"Gomez","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"10.1016\/j.lana.2025.101090_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010386","article-title":"Use of benznidazole to treat chronic Chagas disease: an updated systematic review with a meta-analysis","volume":"16","author":"Crespillo-Andujar","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"10.1016\/j.lana.2025.101090_bib30","doi-asserted-by":"crossref","first-page":"e303","DOI":"10.1093\/cid\/ciaa1101","article-title":"Use of a latent class analysis in the diagnosis of chronic Chagas disease in the Washington metropolitan Area","volume":"72","author":"Castro-Sesquen","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.lana.2025.101090_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab096","article-title":"Evaluation of 2 lateral flow rapid tests in the diagnosis of Chagas disease in the Washington metropolitan Area","volume":"8","author":"Castro-Sesquen","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.lana.2025.101090_bib32","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1186\/s13071-016-1918-2","article-title":"Geographical, landscape and host associations of Trypanosoma cruzi DTUs and lineages","volume":"9","author":"Izeta-Alberdi","year":"2016","journal-title":"Parasit Vectors"},{"issue":"1","key":"10.1016\/j.lana.2025.101090_bib33","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41597-022-01452-w","article-title":"Discrete typing units of Trypanosoma cruzi: geographical and biological distribution in the Americas","volume":"9","author":"Velasquez-Ortiz","year":"2022","journal-title":"Sci Data"},{"issue":"2","key":"10.1016\/j.lana.2025.101090_bib34","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/cid\/cix277","article-title":"Toward improving early diagnosis of congenital Chagas disease in an endemic setting","volume":"65","author":"Messenger","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.lana.2025.101090_bib35","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1128\/jcm.34.9.2143-2147.1996","article-title":"Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas' disease","volume":"34","author":"Umezawa","year":"1996","journal-title":"J Clin Microbiol"},{"issue":"12","key":"10.1016\/j.lana.2025.101090_bib36","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"3","key":"10.1016\/j.lana.2025.101090_bib37","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"issue":"5","key":"10.1016\/j.lana.2025.101090_bib38","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.lana.2025.101090_bib39","article-title":"Fast gene set enrichment analysis","author":"Korotkevich","year":"2021","journal-title":"bioRxiv"},{"issue":"6","key":"10.1016\/j.lana.2025.101090_bib40","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.celrep.2019.01.041","article-title":"RNA-seq signatures normalized by mRNA abundance allow absolute deconvolution of human immune cell types","volume":"26","author":"Monaco","year":"2019","journal-title":"Cell Rep"},{"issue":"7","key":"10.1016\/j.lana.2025.101090_bib41","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.lana.2025.101090_bib42","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol"},{"issue":"6","key":"10.1016\/j.lana.2025.101090_bib43","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S1074-7613(00)80148-X","article-title":"Separate pathways for antigen presentation by CD1 molecules","volume":"11","author":"Sugita","year":"1999","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.lana.2025.101090_bib44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2567.2009.03155.x","article-title":"Efficiency of T-cell costimulation by CD80 and CD86 cross-linking correlates with calcium entry","volume":"129","author":"Thiel","year":"2010","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.lana.2025.101090_bib45","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000350523","article-title":"CD300c is an activating receptor expressed on human monocytes","volume":"5","author":"Simhadri","year":"2013","journal-title":"J Innate Immun"},{"issue":"10","key":"10.1016\/j.lana.2025.101090_bib46","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/ni.1782","article-title":"Activation of innate immune antiviral responses by Nod 2","volume":"10","author":"Sabbah","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.lana.2025.101090_bib47","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3389\/fimmu.2018.00486","article-title":"CD161 defines a functionally distinct subset of pro-inflammatory natural killer cells","volume":"9","author":"Kurioka","year":"2018","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.lana.2025.101090_bib48","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.celrep.2014.09.045","article-title":"CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages","volume":"9","author":"Fergusson","year":"2014","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.lana.2025.101090_bib49","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1038\/s41467-019-10018-1","article-title":"Killer-like receptors and GPR56 progressive expression defines cytokine production of human CD4(+) memory T cells","volume":"10","author":"Truong","year":"2019","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.lana.2025.101090_bib50","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1074-7613(00)80574-9","article-title":"Association of DAP12 with activating CD94\/NKG2C NK cell receptors","volume":"8","author":"Lanier","year":"1998","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.lana.2025.101090_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0355-7","article-title":"Mitochondrial dysfunction and oxidative stress in heart disease","volume":"51","author":"Peoples","year":"2019","journal-title":"Exp Mol Med"},{"issue":"1","key":"10.1016\/j.lana.2025.101090_bib52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nri979","article-title":"Intracellular pathways of CD1 antigen presentation","volume":"3","author":"Moody","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"41","key":"10.1016\/j.lana.2025.101090_bib53","doi-asserted-by":"crossref","first-page":"26923","DOI":"10.1074\/jbc.273.41.26923","article-title":"The early growth response protein (EGR-1) regulates interleukin-2 transcription by synergistic interaction with the nuclear factor of activated T cells","volume":"273","author":"Decker","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lana.2025.101090_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2019.103974","article-title":"Diminished mitogen-induced T cell proliferation by Trypanosoma cruzi antigens associated with antigen-presenting cell modulation and CD3 signaling","volume":"348","author":"Gomez-Olarte","year":"2020","journal-title":"Cell Immunol"},{"issue":"4","key":"10.1016\/j.lana.2025.101090_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095977","article-title":"Trypanosoma cruzi infection down-modulates the immunoproteasome biosynthesis and the MHC class I cell surface expression in HeLa cells","volume":"9","author":"Camargo","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.lana.2025.101090_bib56","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/intimm\/dxf077","article-title":"Trypanosoma cruzi down-regulates lipopolysaccharide-induced MHC class I on human dendritic cells and impairs antigen presentation to specific CD8(+) T lymphocytes","volume":"14","author":"Van Overtvelt","year":"2002","journal-title":"Int Immunol"},{"issue":"5","key":"10.1016\/j.lana.2025.101090_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035966","article-title":"Inhibitory receptors are expressed by Trypanosoma cruzi-specific effector T cells and in hearts of subjects with chronic Chagas disease","volume":"7","author":"Arguello","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.lana.2025.101090_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057181","article-title":"Elevated serum levels of macrophage migration inhibitory factor are associated with progressive chronic cardiomyopathy in patients with Chagas disease","volume":"8","author":"Cutrullis","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.lana.2025.101090_bib59","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.imbio.2012.04.008","article-title":"Foxp3+CD25(high) CD4+ regulatory T cells from indeterminate patients with Chagas disease can suppress the effector cells and cytokines and reveal altered correlations with disease severity","volume":"217","author":"de Araujo","year":"2012","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.lana.2025.101090_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009059","article-title":"A proportion of CD4+ T cells from patients with chronic Chagas disease undergo a dysfunctional process, which is partially reversed by benznidazole treatment","volume":"15","author":"Perez-Anton","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.lana.2025.101090_bib61","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/intimm\/8.1.13","article-title":"Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease","volume":"8","author":"Tarleton","year":"1996","journal-title":"Int Immunol"},{"issue":"12","key":"10.1016\/j.lana.2025.101090_bib62","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1128\/iai.61.12.5129-5133.1993","article-title":"Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei","volume":"61","author":"Rottenberg","year":"1993","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.lana.2025.101090_bib63","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/CIRCRESAHA.116.308030","article-title":"Chronic heart failure and inflammation: what do we really know?","volume":"119","author":"Dick","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.lana.2025.101090_bib64","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1007\/s11357-024-01121-3","article-title":"RelA-mediated signaling connects adaptation to chronic cardiomyocyte stress with myocardial and systemic inflammation in the ADCY8 model of accelerated ageing","volume":"46","author":"Kumar","year":"2024","journal-title":"GeroScience"},{"issue":"10","key":"10.1016\/j.lana.2025.101090_bib65","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.molmed.2007.08.003","article-title":"The peripheral-blood transcriptome: new insights into disease and risk assessment","volume":"13","author":"Mohr","year":"2007","journal-title":"Trends Mol Med"},{"issue":"3","key":"10.1016\/j.lana.2025.101090_bib66","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.trim.2007.08.001","article-title":"FOXP3 mRNA expression analysis in the peripheral blood and allograft of heart transplant patients","volume":"18","author":"Dijke","year":"2008","journal-title":"Transpl Immunol"},{"issue":"6","key":"10.1016\/j.lana.2025.101090_bib67","article-title":"SBC guideline on the diagnosis and treatment of patients with cardiomyopathy of Chagas disease - 2023","volume":"120","author":"Marin-Neto","year":"2023","journal-title":"Arq Bras Cardiol"},{"issue":"3","key":"10.1016\/j.lana.2025.101090_bib68","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/jac\/dkz473","article-title":"Tolerance to nifurtimox and benznidazole in adult patients with chronic Chagas' disease","volume":"75","author":"Jackson","year":"2020","journal-title":"J Antimicrob Chemother"}],"container-title":["The Lancet Regional Health - Americas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X25001000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X25001000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:55:53Z","timestamp":1762642553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667193X25001000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":67,"alternative-id":["S2667193X25001000"],"URL":"https:\/\/doi.org\/10.1016\/j.lana.2025.101090","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.10.03.560680","asserted-by":"object"}]},"ISSN":["2667-193X"],"issn-type":[{"value":"2667-193X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunologic changes in the peripheral blood transcriptome of individuals with early-stage chronic Chagas cardiomyopathy: a cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Americas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lana.2025.101090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101090"}}